The conversation around AI in life sciences manufacturing has shifted. It is no longer a question of whether the technology will arrive but whether organisations are ready to receive it responsibly. Ahead of his talk at the Life Sciences Industry Conference 2026, Ger McCabe, Managing Director and Co-Owner of Biostor Ireland, shared what that readiness looks like, and why the window to get it right may be narrower than many leaders realise.

For McCabe, the urgency of 2026 comes down to timing. "Agencies like the FDA and EMA are recognising AI's emergence and supporting transparency, reproducibility, and human accountability," he explains. "Companies embracing AI now have the opportunity to build validation, traceability, and audit requirements into their AI models while the rules are still being interpreted." Early movers are not simply gaining efficiency advantages, they are gaining the ability to define compliance on their own terms.

When asked what needs to happen before AI can scale successfully, his answer is pointed. "Workforce confidence is a big factor across all teams. Data integrity, traceability, validation, regulation, training, and just as importantly, failure mode behaviours and the human reviewer or reviewers."

His picture of a truly AI-ready site is equally grounded. "Governance is key. Every AI system has a clear owner, a documented validated status, and AI model changes are treated with the same rigour as a change control. Traceability and data is intact, complete, and human reviewed, with no unexplainable gaps." Leadership, he adds, should always know which systems are fixed and validated and which are still learning, with a fallback to manual processes in place.

The one question he believes every life sciences leader should be sitting with: "Maybe AI isn't going away. So what can adoption do for my business?"

On what draws him back to events like this, McCabe's answer reflects the community he has spent a career within. "The Irish life sciences network is known for punching well above its weight. That brings huge learnings to the community and supports leaders to drive continuous development and embrace new technologies together."

Ger McCabe will be speaking at the Life Sciences Industry Conference 2026 on 22nd October at the Crowne Plaza Hotel, Santry. Full details and registration are available at pharmaawards.ie/conference, and subscribe to the newsletter to stay informed on speaker announcements and agenda updates.